Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-14-034015
Filing Date
2014-02-04
Accepted
2014-02-04 08:35:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d667910d424b5.htm 424B5 489070
2 GRAPHIC g6679101.jpg GRAPHIC 8911
3 GRAPHIC g667910g53z14.jpg GRAPHIC 8930
  Complete submission text file 0001193125-14-034015.txt   515121
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-172686 | Film No.: 14570137
SIC: 2835 In Vitro & In Vivo Diagnostic Substances